🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Allo-RevCAR01-T-CD123 drug is a combination of a cellular component (Al...
Status
Recruiting
Location
Universitätsklinikum Ulm
Start Date
2024-01-03
Trial ID
NCT05949125
This dose-escalating phase I trial assesses for the first time the safety, ...
Status
Terminated
Location
Universitätsklinikum Ulm
Start Date
2020-11-23
Trial ID
NCT04633148
Treatments Being Tested
This is a single-arm trial that will evaluate the safety and feasibility of...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2019-09-27
Trial ID
NCT04052334
Treatments Being Tested
This is an investigator-initiated, single-center, single-arm, open-label ex...
Status
Recruiting
Location
Traditional Chinese and Western Medicine Hospital of Wuhan, Wuhan, Hubei
Start Date
2026-01-15
Trial ID
NCT07681388
Treatments Being Tested
This dose-escalating phase I trial assesses for the first time the safety, ...
Status
Terminated
Location
Universitätsklinikum Ulm
Start Date
2020-01-28
Trial ID
NCT04230265
Treatments Being Tested
This study is testing Allo-QuadCAR01-T, a new off-the-shelf CAR-T therapy f...
Status
Recruiting
Location
University of Chicago
Start Date
2026-01-06
Trial ID
NCT07284433